Evaluate the Effects of Patupilone on the Pharmacokinetics and Pharmacodynamics of Warfarin in Patients With Advanced Malignancies

The Catheter Study: Central Venous Catheter Survival in Cancer Patients Using Low Molecular Weight Heparin (Dalteparin) for the Treatment of Deep Vein Thrombosis

NCT00216866 ·Status: COMPLETED ·Phase: PHASE2

Anticoagulation Length of ThErapy and Risk of New Adverse evenTs In Venous thromboEmbolism Study

NCT03292666 ·Status: COMPLETED

Thromboprophylaxis With Rivaroxaban In Patients With Malignancy and Central Venous Lines

NCT03506815 ·Status: COMPLETED ·Phase: PHASE3

Fondaparinux as Monotherapy for DVT and/or Pulmonary Embolism

NCT00413504 ·Status: COMPLETED ·Phase: NA

The Appropriate Anticoagulation Duration for Chronic Obstructive Pulmonary Disease With Pulmonary Thromboembolism

NCT03185845 ·Status: UNKNOWN ·Phase: NA

A Study of Belinostat in Combination With Warfarin in Patients With Solid Tumors or Hematological Malignancies

NCT01317927 ·Status: COMPLETED ·Phase: PHASE1

Rivaroxaban and Vitamin K Antagonists for the Anticoagulation for the Implantation of Vena Cava Filters

NCT04066764 ·Status: RECRUITING ·Phase: PHASE3

DU-176b Phase 2 Dose Finding Study in Subjects With Non-valvular Atrial Fibrillation

NCT00806624 ·Status: COMPLETED ·Phase: PHASE2

Protocol-based Management and Perioperative Outcomes in Patients With Chronic Antithrombotic Therapy

NCT04852406 ·Status: RECRUITING ·Phase: NA

A Healthy Volunteer Study to Evaluate for a Single Dose of 4 Different Tablets of DPOC-4088 the Absorption and Elimination From the Body and the Potential Effect on Blood Clotting

NCT01347203 ·Status: COMPLETED ·Phase: PHASE1

Odiparcil For The Prevention Of Venous Thromboembolism

NCT00244725 ·Status: COMPLETED ·Phase: PHASE2

Apixaban in Thrombocytopenia

NCT06886516 ·Status: RECRUITING ·Phase: EARLY_PHASE1

Improving Anticoagulant Therapy Through Warfarin Metabolite Profiling

NCT01964794 ·Status: COMPLETED

AntiThrombotic Therapy to Ameliorate Clinical Complications in Community Acquired Pneumonia

NCT05848713 ·Status: RECRUITING ·Phase: PHASE3

Study to Compare Pharmacokinetics & Pharmacodynamics of Warfarin & Esmolol in the Absence & Presence of MEDI0382

NCT03347968 ·Status: COMPLETED ·Phase: PHASE1

A Study to Explore the Pharmacodynamic Changes When Transitioning From Rivaroxaban to Warfarin in Healthy Volunteers

NCT01400646 ·Status: COMPLETED ·Phase: PHASE1

Apixaban for the Treatment of Venous Thromboembolism in Patients With Cancer

NCT03045406 ·Status: COMPLETED ·Phase: PHASE3

Comparative Analysis of Injectable Anticoagulants for Thromboprophylaxis Post Cancer-related Surgery

NCT01444612 ·Status: COMPLETED

Phase 2 Healthy Volunteer Study to Evaluate the Ability of PRT064445 to Reverse the Effects of Several Blood Thinner Drugs on Laboratory Tests (Module 2 of 4)

NCT03578146 ·Status: COMPLETED ·Phase: PHASE2

3 Months' Versus 6 Months' Anticoagulation in Patients With DVT and/or PE

NCT00365950 ·Status: COMPLETED ·Phase: PHASE4

Oral Anticoagulant Therapy for Venous Thrombosis - SCOR in Thrombosis

NCT00005684 ·Status: COMPLETED

Phase 2 Healthy Volunteer Study to Evaluate the Ability of PRT064445 to Reverse the Effects of Several Blood Thinner Drugs on Laboratory Tests (Module 1 of 4)

NCT01758432 ·Status: COMPLETED ·Phase: PHASE2

The Efficacy and Safety of Dabigatran Etexilate for the Treatment of Cerebral Venous Thrombosis

NCT03217448 ·Status: UNKNOWN ·Phase: PHASE3

Reversal of the Antithrombotic Action of New Oral Anticoagulants

NCT01478282 ·Status: UNKNOWN ·Phase: PHASE4

Rivaroxaban for Scheduled Work-up of DVT - The Ri-Schedule Study

NCT02486445 ·Status: COMPLETED ·Phase: PHASE3